Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Michael Altose, MD, PhD

Michael Altose, MD, PhD

  • Languages Spoken: English

Biography: Michael Altose, MD, PhD

Expertise

  • General Anesthesiology
  • Medical Education
  • Neuroanesthesia
  • Simulation Medicine

Titles

  • Section Head, Neuroanesthesia, UH Cleveland Medical Center
  • Medical Director, Anesthesia Simulation Lab, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Anesthesiology - American Board of Anesthesiology

Education

Residency | Anesthesiology
Anesthesiology - Uh Case Medical Center (2005 - 2008)

Internship | Anesthesiology
Anesthesiology - University Hospitals Of Cleveland (2004 - 2005)

Medical Education
Case Western Reserve University School Of Medicine (2004)

Other Education
Case Western Reserve University School Of Medicine (2002)

Undergraduate
Brandeis University (1996)

About

Michael D. Altose, MD, PhD, is an anesthesiologist at University Hospitals and is section chief for neurosurgical anesthesia and medical director for the anesthesia simulation lab. He is an associate professor at Case Western Reserve University School of Medicine and is board certified in anesthesiology.

A Cleveland native, Dr. Altose earned his undergraduate degree at Brandeis University and his medical degree at Case Western Reserve University School of Medicine. He completed residency training in anesthesiology at University Hospitals.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Michael Altose did not disclose any Outside Relationships with Industry.